Table 2.
Selected PET and related theranostic agents that have received regulatory approvals or are nearing regulatory approvals.
| Agent | Name | Commercial Name | Target | Approval Date |
|---|---|---|---|---|
| 68Ga-DOTATATE | DOTATATE | NETSPOT™ | Neuroendocrine | 08/21/19 |
| 68Ga-PSMA-11 | TLX591-CDX | ILLUMET™ | Prostate cancer, PSMA | 12/01/20 |
| 18F-DCFPyL | F-18-piflufolastat | PYLARIFY® | Prostate cancer, PSMA | 05/27/21 |
| 177Lu-PSMA-617 | Lu 177-dotatate | Lutathera® | Neuroendocrine | 01/26/18 |